Chongqing Pharscin Pharmaceutical Co Ltd (002907) — Cash Flow Quality Index
Chongqing Pharscin Pharmaceutical Co Ltd (002907) has a Cash Flow Quality Index of 0.05x as of September 2025. Operating cash flow of CN¥833.94K is below net income of CN¥18.51 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore how efficiently does Chongqing Pharscin Pharmaceutical Co Ltd generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chongqing Pharscin Pharmaceutical Co Ltd Cash Flow Quality Index (2013–2024)
Historical Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 002907 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Chongqing Pharscin Pharmaceutical Co Ltd (2013–2024)
Year-by-year earnings quality comparison for Chongqing Pharscin Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Chongqing Pharscin Pharmaceutical Co Ltd (002907) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.11x | CN¥161.77 Million | CN¥76.73 Million | ▼ -68.6% |
| 2023 | 6.71x | CN¥219.34 Million | CN¥32.70 Million | ▲ +4959.9% |
| 2022 | 0.13x | CN¥13.04 Million | CN¥98.40 Million | ▼ -85.3% |
| 2021 | 0.90x | CN¥82.85 Million | CN¥91.78 Million | ▼ -5.3% |
| 2020 | 0.95x | CN¥113.64 Million | CN¥119.19 Million | ▲ +145.5% |
| 2019 | 0.39x | CN¥65.92 Million | CN¥169.75 Million | ▲ +67.8% |
| 2018 | 0.23x | CN¥31.80 Million | CN¥137.37 Million | ▼ -68.1% |
| 2017 | 0.73x | CN¥81.34 Million | CN¥111.99 Million | ▲ +20.4% |
| 2016 | 0.60x | CN¥57.73 Million | CN¥95.71 Million | ▼ -33.7% |
| 2015 | 0.91x | CN¥66.10 Million | CN¥72.69 Million | ▲ +166.7% |
| 2014 | 0.34x | CN¥20.22 Million | CN¥59.30 Million | ▼ -79.1% |
| 2013 | 1.64x | CN¥47.34 Million | CN¥28.95 Million | — |